The U.S. Food and Drug Administration (FDA) has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method to […]
Clinical Researcher—August 2020 (Volume 34, Issue 7) PEER REVIEWED Yaritza Peña; Zachary P. Smith; Kenneth A. Getz, MBA It is well known that the underrepresentation of minority groups in […]
Clinical Researcher—August 2020 (Volume 34, Issue 7) PEER REVIEWED Mario Esquivel, MS, ACRP-CP Tobacco use in the United States amongst adults has consistently been the leading cause of preventable […]
Clinical Researcher—August 2020 (Volume 34, Issue 7) SPECIAL FEATURE Isabelle Yates; Jennifer Byrne; Susan Donahue, CCRC, ACRP-PM; Linda McCarty, JD; Allison Mathews In a recent report from the U.S. […]
Clinical Researcher—August 2020 (Volume 34, Issue 7) SPECIAL FEATURE Achenyo Ochuma, MSc The emergence of the COVID-19 pandemic has resulted in a significant impact globally across various sectors and […]